Windtree Therapeutics, Inc.
Market Cap
$674.18K
P/E Ratio
—
EPS
$323.08
Dividend Yield
0.00%
52-Week Range
$0.01 — $3.48
Volume
1.40M
Avg Volume
390.25K
Beta
0.80
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
3.75
P/B (TTM)
-0.00
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-13.03%
ROA (TTM)
-2.50%
ROIC
—
Gross Margin
0.12%
Operating Margin
-372.19%
Net Margin
—
Debt/Equity
-1.11
Current Ratio
0.33
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.81%
EPS Growth (5Y)
+0.46%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
-0.20%
EPS Est (This Year)
$-549.00
EPS Est (Next Year)
$-567.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$7.65
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
33.71M
Float
33.71M
Free Float %
100.00%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
1995-08-07
Employees
14
CEO
Jed A. Latkin
Index Membership
—
Website
https://windtreetx.com
Windtree Therapeutics, Inc. (WINT) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $674.18K, WINT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare WINT against other stocks using dozens of fundamental and technical filters.
No, Windtree Therapeutics, Inc. (WINT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Windtree Therapeutics, Inc. (WINT) has a market capitalization of $674,176, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.